secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2022-04-25T23:59:59+00:00
Accession:  0000950170-22-006093
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medpace Q1 revenue up 27.3% to $330.9M; EPS $1.69 vs $1.14 YoY
--------------------------------------------------------------

- Revenue $330.9M, +27.3% YoY; constant-currency organic growth +28.1%.
- GAAP EPS $1.69 diluted vs $1.14 prior year; net income margin 18.5% (prev 16.7%).
- Net new business awards $423.0M (+18.8% YoY); book-to-bill ratio 1.28x.
- Backlog grew 28.0% to $2.1B from $1.6B as of Mar 31, 2021.
- EBITDA $70.4M (+31.3%); margin 21.3% vs 20.6% prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022006093/0000950170-22-006093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022006093/medp-20220425.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-006093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer